Cognitive behavioral therapy for anxiety and opioid use disorder: Development and pilot testing.
McHugh RK, Fitzmaurice GM, Votaw VR, Geyer RB, Ragnini K, Greenfield SF, Weiss RD.
J Subst Use Addict Treat. 2024 Jan 24. 160:209296. PMID: 38272120
Professor of Psychiatry
Psychiatry-McLean Hospital
Harvard Medical School
McHugh RK, Fitzmaurice GM, Votaw VR, Geyer RB, Ragnini K, Greenfield SF, Weiss RD.
J Subst Use Addict Treat. 2024 Jan 24. 160:209296. PMID: 38272120
BraƱas MJAA, Frankenburg FR, Temes CM, Fitzmaurice GM, Zanarini MC.
J Clin Psychiatry. 2023 Nov 08. 84(6). PMID: 37943989
Bitran AM, Temes CM, Gecha TC, Glass IV, Frankenburg FR, Fitzmaurice GM, Zanarini MC.
J Pers Disord. 2023 Nov. 37(6):678-690. PMID: 38038657
Ren B, Lipsitz SR, Weiss RD, Fitzmaurice GM.
Stat Methods Med Res. 2023 10. 32(10):1973-1993. PMID: 37647237
Zanarini MC, Hein KE, Temes CM, Frankenburg FR, Fitzmaurice GM.
J Pers Disord. 2023 08. 37(4):456-468. PMID: 37721779
Ren B, Lipsitz SR, Weiss RD, Fitzmaurice GM.
Drug Alcohol Depend. 2023 09 01. 250:110897. PMID: 37544038
Whitton AE, Kumar P, Treadway MT, Rutherford AV, Ironside ML, Foti D, Fitzmaurice G, Du F, Pizzagalli DA.
Mol Psychiatry. 2023 Jul 04. PMID: 37402852
Ren B, Lipsitz SR, Fitzmaurice GM, Weiss RD.
Multivariate Behav Res. 2024 Jan-Feb. 59(1):110-122. PMID: 37379399
Zanarini MC, Martinho E, Temes CM, Glass IV, Aguirre BA, Goodman M, Fitzmaurice GM.
Borderline Personal Disord Emot Dysregul. 2023 Mar 09. 10(1):9. PMID: 36895048
McHugh RK, Votaw VR, McCarthy MD, Bichon JA, Bailey AJ, Fitzmaurice GM.
J Addict Med. 2023 May-Jun 01. 17(3):326-332. PMID: 37267178